The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT
NCT ID: NCT00959205
Last Updated: 2010-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
160 participants
INTERVENTIONAL
2009-07-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus
NCT04223505
Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms
NCT02057588
Left Ventricular Myocardial Work for Predicting Response to CRT
NCT07319065
Optimization of an Automated Ultrasound Cardiac Guidance Tool
NCT04981444
Role of 3D Echocardiography Knowledge-based Reconstruction in ACHD
NCT06282926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Angiography
Conventional fluoroscopically guided activation mapping
Angiography
Conventional fluoroscopically guided activation mapping
CARTO 3D
CARTO (3D Electroanatomic imaging)
CARTO 3D
CARTO (3D Electroanatomic imaging)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CARTO 3D
CARTO (3D Electroanatomic imaging)
Angiography
Conventional fluoroscopically guided activation mapping
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Korea medical center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kim Young-Hoon, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Korea medical center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Korea medical center
Seoul, , South Korea
Asan Medical Center
Seoul, , South Korea
Seoul National University Hospital/Internal Medicine
Seoul, , South Korea
Seoul St. Mary's Hospital
Seoul, , South Korea
Severance Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009_KU_CARTO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.